Driven by Respect, Growth, and Pride the culture atspeaks about doing things together as a team, in the right way, supporting each other, so that our suppliers, customers, and partners grow along with us. We wish to make a lasting, positive change to the market.
You are offered to be part in the forefront of the dynamic, growing world of cloud computing and computer component distribution. This is an opportunity to work in a highly professional, entrepreneurial and driven environment backed by data analytics, and the best in class qualitycertifications.
What You'll Be Doing
What We Are Looking For
What's In It For You
At Converge, an Arrow company, we recognize that financial rewards and excellent benefits are essential aspects of an ideal job. That's why we offer competitive financial compensation, including various compensation plans and a solid benefits package.
And more!
Converges Account Managers have the knowledge and tools to provide data-driven solutions for even the most demanding supply-chain challenges. These professionals provide expert support and dedicated customer service solutions to our clients.
If this sounds like the career for you,
Apply today!
Actual compensation offer to candidate may vary from posted hiring range based upon geographic location, work experience, education, and/or skill level. The pay ratio between base pay and target incentive (if applicable) will be finalized at offer.
Location:US-MA-Peabody, Massachusetts (Technology Dr)Time Type:Full timeJob Category:SalesEEO Statement:Arrow is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, gender, age, sexual orientation, gender identity, national origin, veteran or disability status.
Arrow COVID-19 Vaccination Policy:Arrow requires employees to provide proof of full COVID-19 vaccination by:
* December 1, 2021, for all positions located in CO and for business units within immixGroup and Zeus.
* All other employees will be required to identify vaccination status by December 1, 2021, and provide proof of full vaccination by January 3, 2022.